G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024
April 17 2024 - 9:00AM
G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology
company, will host a webcast and conference call to provide a
financial and corporate update for the first quarter of 2024 on
Wednesday May 1, 2024, at 8:30 a.m. ET.
To register for the event and receive a dial in
number and unique PIN to access the live conference call, please
follow this link to register online. While not required, it is
recommended that you join 10 minutes prior to the start of the
event. A live and archived webcast will be available on
the Events & Presentations page of the company’s
website: www.g1therapeutics.com. The webcast will be archived on
the same page for 90 days following the event.
About G1 TherapeuticsG1
Therapeutics, Inc. is a commercial-stage oncology biopharmaceutical
company whose mission is to develop and deliver next-generation
therapies that improve the lives of those affected by cancer,
including the Company’s first commercial product, COSELA®
(trilaciclib). The Company is also evaluating therapies in
combination with cytotoxic therapies and/or immunotherapy in areas
of high unmet need including triple-negative breast cancer and
extensive stage small cell lung cancer. G1’s goal is to provide
innovative therapeutic advances for people living with cancer. G1
is based in Research Triangle Park, N.C. For additional
information, please visit http://www.g1therapeutics.com and follow
us on X (formerly known as Twitter) @G1Therapeutics and
LinkedIn.
G1 Therapeutics® and the G1 Therapeutics logo and
COSELA® and the COSELA logo are trademarks of G1
Therapeutics, Inc.
G1 Therapeutics Contacts:
Will RobertsCommunications OfficerVice President,
Investor Relations and Corporate Communications(919) 907-1944
wroberts@g1therapeutics.com
G1 Therapeutics (NASDAQ:GTHX)
Historical Stock Chart
From Apr 2024 to May 2024
G1 Therapeutics (NASDAQ:GTHX)
Historical Stock Chart
From May 2023 to May 2024